This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Arvinas Operations, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations in Breast Cancer Treatment by John Flanagan
Introduction
John Flanagan is an accomplished inventor based in Belmont, MA (US). He has made significant contributions to the field of cancer treatment, particularly in the area of breast cancer. His innovative approach focuses on utilizing tetrahydronaphthalene derivatives as estrogen receptor degraders.
Latest Patents
Flanagan holds a patent for "Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders." This patent addresses the treatment and prevention of breast cancer, including locally advanced or metastatic, ER+, HER2− breast cancer. The application involves administering a compound of Formula (I), or its various acceptable forms, to subjects in need of treatment.
Career Highlights
Flanagan is associated with Arvinas Operations, Inc., where he continues to work on groundbreaking research and development in cancer therapies. His dedication to improving treatment options for breast cancer patients is evident in his innovative patent.
Collaborations
Some of his notable coworkers include Andrew Philip Crew and Sheryl Maxine Gough. Their collaboration contributes to the advancement of research in the field of oncology.
Conclusion
John Flanagan's work exemplifies the impact of innovation in medical treatments, particularly in the fight against breast cancer. His patent represents a significant step forward in providing effective therapies for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile